Resources

Relevant, timely and evidence-based information for Australian health professionals and consumers.

We have many resources available for consumers and health professionals including brochures, fact sheets and translated resources. All of our products are available free of charge.

Corporate documents

Annual reports, budgets, corporate plans, reports

Clinical resources

Fact sheets, action plans, brochures, guidelines, and more for health professionals and consumers

Multimedia

Videos, podcasts, conference recordings, images and Infographics

 

Filter

Sort by:
empty empty

Episode 42: Exploring digital interventions for mental health

  • 19 May 2022
  • Podcasts

Episode 42: Exploring digital interventions for mental health

  • 19 May 2022
  • Podcasts

In this episode, NPS MedicineWise medical advisor Dr Caroline West speaks with Dr Michael Millard, director of the clinical research unit for anxiety and depression at St. Vincent's Hospital. They discuss how early interventions with effective support, engagement and management of course can make all the difference to young people and their mental health.




Further reading

NPS MedicineWise Mental health and young people: opportunities to empower and engage

NPS MedicineWise podcast Mental health and young people: two personal stories

This Way Up thiswayup.org.au


Immunoglobulin management and wellbeing plan Immunoglobulin management and wellbeing plan

Immunoglobulin management and wellbeing plan

  • 6 June 2022
  • Patient action plans

Immunoglobulin management and wellbeing plan

  • 6 June 2022
  • Patient action plans
Immunoglobulin replacement therapy for acquired hypogammaglobulinaemia secondary to haematological malignancies and stem cell transplantation (coming soon) Immunoglobulin replacement therapy for acquired hypogammaglobulinaemia secondary to haematological malignancies and stem cell transplantation (coming soon)

Immunoglobulin replacement therapy for acquired hypogammaglobulinaemia secondary to haematological malignancies and stem cell transplantation (coming soon)

  • 16 June 2022
  • Clinical algorithms and tools

Immunoglobulin replacement therapy for acquired hypogammaglobulinaemia secondary to haematological malignancies and stem cell transplantation (coming soon)

  • 16 June 2022
  • Clinical algorithms and tools
Immunoglobulin replacement therapy for secondary hypogammaglobulinaemia Immunoglobulin replacement therapy for secondary hypogammaglobulinaemia

Immunoglobulin replacement therapy for secondary hypogammaglobulinaemia

  • 15 June 2022
  • Fact sheets and FAQs

Immunoglobulin replacement therapy for secondary hypogammaglobulinaemia

  • 15 June 2022
  • Fact sheets and FAQs
Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

  • 16 June 2022
  • Clinical algorithms and tools

Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

  • 16 June 2022
  • Clinical algorithms and tools
Immunoglobulin replacement therapy for primary immunodeficiencies Immunoglobulin replacement therapy for primary immunodeficiencies

Immunoglobulin replacement therapy for primary immunodeficiencies

  • 16 June 2022
  • Fact sheets and FAQs

Immunoglobulin replacement therapy for primary immunodeficiencies

  • 16 June 2022
  • Fact sheets and FAQs
Immunoglobulin products: when to reduce or stop treatment Immunoglobulin products: when to reduce or stop treatment

Immunoglobulin products: when to reduce or stop treatment

  • 15 June 2022
  • Clinical algorithms and tools

Immunoglobulin products: when to reduce or stop treatment

  • 15 June 2022
  • Clinical algorithms and tools
Immunoglobulin replacement therapy for primary immunodeficiency: recommendations for moving from paediatric to adult care Immunoglobulin replacement therapy for primary immunodeficiency: recommendations for moving from paediatric to adult care

Immunoglobulin replacement therapy for primary immunodeficiency: recommendations for moving from paediatric to adult care

  • 6 June 2022
  • Patient decision aids

Immunoglobulin replacement therapy for primary immunodeficiency: recommendations for moving from paediatric to adult care

  • 6 June 2022
  • Patient decision aids
Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment. Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment.

Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment.

  • 15 June 2022
  • Clinical algorithms and tools

Immunoglobulin products: when to reduce or stop treatment This action plan informs and empowers patients to participate in changes to their treatment.

  • 15 June 2022
  • Clinical algorithms and tools
Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

  • 16 June 2022
  • Clinical algorithms and tools

Immunoglobulin dose adjustment, weaning and cessation: a conversation guide for health professionals

  • 16 June 2022
  • Clinical algorithms and tools